Alimera Sciences Inc's (ALIM) Outlook - CSIMarket
CSIMarket
 
Alimera Sciences Inc  (NASDAQ: ALIM)
 



  Alimera Sciences Inc Outlook

On March 7 2024 the Alimera Sciences Inc provided following guidance

Alimera Sciences Inc. has reported significant growth in its financial performance for the fourth quarter and full year of 2023. In the fourth quarter, net revenues increased by 88% to $26.3 million compared to the same period in 2022. Similarly, for the full year of 2023, net revenues rose by 49% to $80.8 million compared to 2022.

The company also announced an increase in its revenue guidance for 2024, reflecting confidence in its future growth prospects. This uptick in revenue suggests that Alimera Sciences Inc. is on track to continue its success and achieve even stronger financial results in the coming years.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.